Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kJ/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Glutamate receptor ionotropic, NMDA 2B (Homo sapiens (Human)) | BDBM280730 (US10030026, Compound C-12) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 23 | n/a | n/a | n/a | n/a | n/a | 25 |
Rugen Holdings (Cayman) Limited US Patent | Assay Description HEK293 cell lines stably expressing cloned human NR1/NR2B and NR1/NR2A, respectively, were established according to standard previously described met... | US Patent US10030026 (2018) BindingDB Entry DOI: 10.7270/Q26D5W1Q | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Glutamate receptor ionotropic, NMDA 2B (Homo sapiens (Human)) | BDBM280730 (US10030026, Compound C-12) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.00E+7 | n/a | n/a | n/a | n/a | n/a | n/a |
Rugen Holdings (Cayman) Limited US Patent | US Patent US10030026 (2018) BindingDB Entry DOI: 10.7270/Q26D5W1Q | ||||||||||||
More data for this Ligand-Target Pair |